Skip to main content
Veterinary Medicines

Gletvax 6 vakcina A.U.V.

Authorised
  • Escherichia coli, fimbrial adhesin F6
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F4ab
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid

Product identification

Medicine name:
Gletvax 6 vakcina A.U.V.
Active substance:
  • Escherichia coli, fimbrial adhesin F6
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F4ab
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type B and C, beta toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, fimbrial adhesin F6
  • Escherichia coli, fimbrial adhesin F5
  • Escherichia coli, fimbrial adhesin F4ac
  • Escherichia coli, fimbrial adhesin F4ab
  • Clostridium perfringens, type D, epsilon toxoid
    200.00
    unit(s)
    /
    1.00
    unit(s)/dose
  • Clostridium perfringens, type B and C, beta toxoid
    300.00
    unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change: